Skip to content
Open access

DOES RS11191580 NT5C2 AND DRD2-141C INS/DEL POLYMOPRHIMSM AFFECT SCHIZOPHRENIA SYMPTOMS SEVERITY IN BATAK POPULATION

Jul 2026 · F1000Research · Vol 15, pp. 1126 · 0 citations · 15 references

TL;DR

Both NT5C2 rs11191580 and DRD2 − 141C Ins/Del polymorphisms were associated with schizophrenia susceptibility in the Batak population but not with symptom severity.

Abstract

Introduction Schizophrenia is a highly heritable psychiatric disorder with a complex genetic architecture. Variants in NT5C2 and DRD2 have been implicated in schizophrenia susceptibility; however, their relationships with symptom severity and cognitive impairment remain inconsistent across different ethnic populations. This study investigated the association of NT5C2 rs11191580 and DRD2 − 141C Ins/Del polymorphisms with schizophrenia, psychopathology, and cognitive function in the Batak population of North Sumatra, Indonesia. Methods A hospital-based case–control study was conducted involving 50 Batak patients with schizophrenia and 50 ethnically matched healthy controls. Genotyping of NT5C2 rs11191580 and DRD2 − 141C Ins/Del polymorphisms was performed using polymerase chain reaction. Psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). Results Significant differences in genotype distributions were observed between schizophrenia patients and healthy controls for NT5C2 rs11191580 (p = 0.022) and DRD2 − 141C Ins/Del (p < 0.001). Neither polymorphism was associated with PANSS severity categories or PANSS total and subscale scores (all p > 0.05). Discussion Both NT5C2 rs11191580 and DRD2 − 141C Ins/Del polymorphisms were associated with schizophrenia susceptibility in the Batak population but not with symptom severity.

Read PDF

Similar papers

Sep 2026

Association Of Snp8nrg241930 Polymorphism in The Neuregulin 1 (Nrg1) Gene with Schizophrenia Susceptibility and Clinical Symptom Improvement Following Risperidone Treatment

Evidence linking neuregulin 1 (NRG1) polymorphisms with schizophrenia susceptibility and antipsychotic response remains inconsistent. This analytical observational study combined a case–control genetic analysis with prospective longitudinal assessment to evaluate SNP8NRG241930 (NRG1 rs62510682) in relation to schizophr...

A. Khadijah · 0 citations
Open access Aug 2026

Association of HTR2A (rs6313) gene polymorphism with autism spectrum disorder in Jordanian children: a case-control study

The findings suggest no significant association between the HTR2A rs6313 and ASD susceptibility in the Jordanian population, and emphasize the need for larger, multi-marker studies to account for regional genetic diversity.

Wiam Khalil, Elaf Adel Al-Dalabeeh, M. Zihlif · 0 citations
Aug 2026

Haplotype-based association of HTR2A rs6311-rs6313 with early risperidone-clozapine response in Batak patients with schizophrenia.

HTR2A variation was associated with early risperidone-clozapine response, with consistent signals under the recessive model and at the haplotype level, and haplotype analysis may provide a more robust approach for detecting pharmacogenetic contributions to treatment response.

Nurul Hidayah, M. Ikawati, M. M. Amin et al. · 0 citations
Aug 2026

Dopamine Receptor D2 gene Polymorphisms rs2005313, rs4274224, and rs4938019 in Pakistani Patients with Schizophrenia:a Diagnostic Tool for Schizophrenia

The research identified highly significant associations across multiple inheritance models, validating the technical robustness of the findings, and establish DRD2 intronic polymorphisms as critical determinants of schizophrenia risk.

Ishrat Yaseen, Saleem Ahmad, Muhammad Ghalib et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.